Grateful to have been able to participate in the early rounds (and work with the founders) of:

• Hummingbird Ventures:
• Amber Bio - RNA editing therapeutics
• Enveda - discovering new medicines from nature
• Kaleidoscope - R&D operations for life sciences
• Kernal Bio - cell-specific mRNA therapeutics
• Pheiron - increasing success rates of drug development with human evidence
• Serna Bio - targeting RNA with small molecules
• Waypoint Bio - cell therapies for solid tumours
• Angel investments:
• alphaXiv - community for scientific publishing
• Babylon Bio - developing drugs for neurological conditions
• Bioptimus - multi-modal models for biology
• Cradle Bio - protein engineering
• Constellation Systems - neurotech
• NanoSyrinx - intracellular protein delivery